Intellectual Property India Publishes Patent Application for 'Adaptive Biomarker-Driven, Ratio-Critical Epigenetic Modulation Platform Comprising Histone Deacetylase Inhibitors And Plant-Derived Polyphenols With Synchronized Controlled Release Architecture' Filed by Swami Vivekanand Subharti University

MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611022870 A) filed by Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, on Feb. 26, for 'adaptive biomarker-driven, ratio-critical epigenetic modulation platform comprising histone deacetylase inhibitors and plant-derived polyphenols with synchronized controlled release architecture.'

Inventor(s) include Priyadarshini Soni; and Akansha Singh.

The application for the patent was published on May 1, under issue no. 18/2026.

According to the abstract released by the Intellectual Property India: "The present invention relates to an adaptive, biomarker-driven, ratio-critical epigenetic modulation platform comprising at least one histone deacet...